PRMT5 and lung carcinoma: In lung cancer, PRMT5 suppressed the transcription of miR‐99 by SDMA of histone H4R3, leading to increased expression of epidermal growth factor receptor 3 and activation of Erk1/2 and Akt, thus facilitating the metastasis [31].